MSF Field Research > 1 Published Research and Commentary > HIV/AIDS > Very early anthropometric changes after antiretroviral therapy predict subsequent survival, in karonga, Malawi.

Please use this identifier to cite or link to this item: http://hdl.handle.net/10144/250134
    Del.icio.us     LinkedIn     Citeulike     Connotea     Facebook     Stumble it!


Download this article:
View/Open File Description Size Format
Thumbnail
View/Open
Very early anthropometric changes after antiretroviral therapy predict subsequent survival in karonga, Malawi.pdf2630KbAdobe PDF

Title: Very early anthropometric changes after antiretroviral therapy predict subsequent survival, in karonga, Malawi.
Authors: Maman, David
Glynn, Judith R
Crampin, Amelia C
Kranzer, Katharina
Saul, Jacqueline
Jahn, Andreas
Mwinuka, Venance
Ngwira, Msenga Hc
Mvula, Hazzie
Munthali, Fipson
McGrath, Nuala
Affiliation: Hospices Civils de Lyon, Service de Biostatistique, Lyon, F-69003, France; Université de Lyon, Lyon, F-69000, France; Université Lyon I, Villeurbanne, F-69100, France; CNRS UMR5558, Laboratoire de Biométrie et Biologie Evolutive, Equipe Biostatistique Santé, Pierre-Bénite, F-69310, France; Epicentre, Paris, France; London School of Hygiene and Tropical Medicine, London, England; Karonga Prevention Study, Malawi; Karonga District Hospital, Karonga, Malawi; Africa Centre for Health and Population Studies, University of KwaZulu Natal, Mtubatuba, South Africa.
Citation: Open Aids J 2012; 6:36-44.
Journal: The Open AIDS Journal
Issue Date: Jun-2012
URI: http://hdl.handle.net/10144/250134
DOI: 10.2174/1874613601206010036
PubMed ID: 22670166
Additional Links: http://benthamscience.com/open/toaidj/articles/V006/36TOAIDJ.pdf
Abstract: Antiretroviral (ART) scale-up in Malawi has been achieved on a large scale based mainly on clinical criteria. Simple markers of prognosis are useful, and we investigated the value of very early anthropometric changes in predicting mortality.
Type: Article
Language: en
Keywords: HIV/AIDS
MeSH: sub-Saharan Africa
Anthropometric measure
antiretroviral therapy
HIV
Mortality
ISSN: 1874-6136
Rights: Archived with thanks to The Open AIDS journal
Appears in topics: HIV/AIDS

Related articles on PubMed
bullet
Assessment of simple risk markers for early mortality among HIV-infected patients in Guinea-Bissau: a cohort study.
Oliveira I, Andersen A, Furtado A, Medina C, da Silva D, da Silva ZJ, Aaby P, Laursen AL, Wejse C, Eugen-Olsen J, Bissau HIV cohort study group
2012
bullet
Clinical predictors cannot replace biological predictors in HIV-2 infection in a community setting in West Africa.
Gourlay AJ, van Tienen C, Dave SS, Vincent T, Rowland-Jones SL, Glynn JR, Whittle HC, van der Loeff MF
2012 May
bullet
What happens to ART-eligible patients who do not start ART? Dropout between screening and ART initiation: a cohort study in Karonga, Malawi.
McGrath N, Glynn JR, Saul J, Kranzer K, Jahn A, Mwaungulu F, Ngwira MH, Mvula H, Munthali F, Mwinuka V, Mwaungulu L, Fine PE, Crampin AC
2010 Oct 12
bullet
Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes.
May M, Boulle A, Phiri S, Messou E, Myer L, Wood R, Keiser O, Sterne JA, Dabis F, Egger M, IeDEA Southern Africa and West Africa
2010 Aug 7
bullet
Nutritional status and mortality among HIV-infected patients receiving antiretroviral therapy in Tanzania.
Liu E, Spiegelman D, Semu H, Hawkins C, Chalamilla G, Aveika A, Nyamsangia S, Mehta S, Mtasiwa D, Fawzi W
2011 Jul 15
See all 80 articles

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.

 

OR Logo Powered by Open Repository | Cookies

My MSF

MSF logo MSF Field Research

Nov 1, 2014